Skip to main content

Breast Cancer Research

Ausgabe 4/2009

Inhalt (28 Artikel)

Open Access Research article

Dynamics of different-sized solid-state nanocrystals as tracers for a drug-delivery system in the interstitium of a human tumor xenograft

Masaaki Kawai, Hideo Higuchi, Motohiro Takeda, Yoshio Kobayashi, Noriaki Ohuchi

Open Access Research article

Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study

Mette Kalager, Tor Haldorsen, Michael Bretthauer, Geir Hoff, Steinar O Thoresen, Hans-Olov Adami

Open Access Research article

Increased levels of active c-Src distinguish invasive from in situ lobular lesions

Donghui Zou, Han-Seung Yoon, Ahmad Anjomshoaa, David Perez, Ryuji Fukuzawa, Parry Guilford, Bostjan Humar

Open Access Research article

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

Bahriye Aktas, Mitra Tewes, Tanja Fehm, Siegfried Hauch, Rainer Kimmig, Sabine Kasimir-Bauer

Open Access Research article

Genomic profiling of breast tumours in relation to BRCAabnormalities and phenotypes

Olafur Andri Stefansson, Jon Gunnlaugur Jonasson, Oskar Thor Johannsson, Kristrun Olafsdottir, Margret Steinarsdottir, Sigridur Valgeirsdottir, Jorunn Erla Eyfjord

Open Access Research article

Alternative use of multiple exons 1 of aromatase gene in cancerous and normal breast tissues from women over the age of 80 years

Naoko Honma, Kaiyo Takubo, Motoji Sawabe, Tomio Arai, Futoshi Akiyama, Goi Sakamoto, Toshiaki Utsumi, Noriko Yoshimura, Nobuhiro Harada

Editorial

Is there more to Wnt signalling in breast cancer than stabilisation of β-catenin?

Giovanna M Collu, Olivier Meurette, Keith Brennan

Open Access Research article

Plasma carotenoids, retinol, and tocopherols and postmenopausal breast cancer risk in the Multiethnic Cohort Study: a nested case-control study

Meira Epplein, Yurii B Shvetsov, Lynne R Wilkens, Adrian A Franke, Robert V Cooney, Loïc Le Marchand, Brian E Henderson, Laurence N Kolonel, Marc T Goodman

Open Access Research article

Presence of HER4 associates with increased sensitivity to Herceptin™ in patients with metastatic breast cancer

Andrea Sassen, Simone Diermeier-Daucher, Manuela Sieben, Olaf Ortmann, Ferdinand Hofstaedter, Stephan Schwarz, Gero Brockhoff

Open Access Research article

Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women

Carolyn J Crandall, Mary E Sehl, Sybil L Crawford, Ellen B Gold, Laurel A Habel, Lesley M Butler, MaryFran R Sowers, Gail A Greendale, Janet S Sinsheimer

Open Access Research article

A novel role for signal transducer and activator of transcription 5b (STAT5b) in β1-integrin-mediated human breast cancer cell migration

Teresa M Bernaciak, Jessica Zareno, J Thomas Parsons, Corinne M Silva

Open Access Research article

Construction of an MUC-1 promoter driven, conditionally replicating adenovirus that expresses the sodium iodide symporter for gene therapy of breast cancer

Miguel A Trujillo, Michael J Oneal, Julia Davydova, Elizabeth Bergert, Masato Yamamoto, John C Morris III

Open Access Research article

Tumor aromatase expression as a prognostic factor for local control in young breast cancer patients after breast-conserving treatment

Marc A Bollet, Alexia Savignoni, Leanne De Koning, Carine Tran-Perennou, Catherine Barbaroux, Armelle Degeorges, Brigitte Sigal-Zafrani, Geneviève Almouzni, Paul Cottu, Rémy Salmon, Nicolas Servant, Alain Fourquet, Patricia de Cremoux

Open Access Research article

An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer

Andrea H Bild, Joel S Parker, Adam M Gustafson, Chaitanya R Acharya, Katherine A Hoadley, Carey Anders, P Kelly Marcom, Lisa A Carey, Anil Potti, Joseph R Nevins, Charles M Perou

Open Access Research article

Breast cancer-associated metastasis is significantly increased in a model of autoimmune arthritis

Lopamudra Das Roy, Latha B Pathangey, Teresa L Tinder, Jorge L Schettini, Helen E Gruber, Pinku Mukherjee

Meeting report

It's all in the details: methods in breast development and cancer

Mohamed Bentires-Alj, Robert B Clarke, Jos Jonkers, Matthew Smalley, Torsten Stein

Open Access Research article

The cytotoxicity of γ-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by γ-secretase inhibition

Jianxun Han, Ivy Ma, Michael J Hendzel, Joan Allalunis-Turner

Open Access Research article

MicroRNA expression profiling of male breast cancer

Matteo Fassan, Raffaele Baffa, Juan P Palazzo, Joshua Lloyd, Marco Crosariol, Chang-Gong Liu, Stefano Volinia, Hannes Alder, Massimo Rugge, Carlo M Croce, Anne Rosenberg

Open Access Research article

Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells

Tanja Fehm, Oliver Hoffmann, Bahriye Aktas, Sven Becker, Erich F Solomayer, Diethelm Wallwiener, Rainer Kimmig, Sabine Kasimir-Bauer

Open Access Research article

Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer

Mark R Pickard, Andrew R Green, Ian O Ellis, Carlos Caldas, Vanessa L Hedge, Mirna Mourtada-Maarabouni, Gwyn T Williams

Open Access Research article

Haploinsufficiency for p190B RhoGAP inhibits MMTV-Neu tumor progression

Brandy M Heckman-Stoddard, Tracy Vargo-Gogola, Peter R McHenry, Vivian Jiang, Matthew P Herrick, Susan G Hilsenbeck, Jeffrey Settleman, Jeffrey M Rosen

Open Access Research article

Resident macrophages influence stem cell activity in the mammary gland

David E Gyorki, Marie-Liesse Asselin-Labat, Nico van Rooijen, Geoffrey J Lindeman, Jane E Visvader

Open Access Research article

BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A

Julian Puppe, Rinske Drost, Xiaoling Liu, Simon A Joosse, Bastiaan Evers, Paulien Cornelissen-Steijger, Petra Nederlof, Qiang Yu, Jos Jonkers, Maarten van Lohuizen, Alexandra M Pietersen

Open Access Research article

Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort

Marjorie L McCullough, Victoria L Stevens, Roshni Patel, Eric J Jacobs, Elizabeth B Bain, Ronald L Horst, Susan M Gapstur, Michael J Thun, Eugenia E Calle

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.